CT findings in patients with Cabazitaxel induced pelvic pain and haematuria: a case series

por Malalagama, Geethal N., Chryssidis, Steve, Parnis, Francis X
Publicado 2017

Real‐world first‐line systemic therapy patterns in metastatic castration‐resistant prostate cancer

por Anton, Angelyn, Pillai, Sruti, Semira, Marie Christine, Wong, Shirley, Shapiro, Julia, Weickhardt, Andrew, Azad, Arun, Kwan, Edmond M., Spain, Lavinia, Gunjur, Ashray, Torres, Javier, Parente, Phillip, Parnis, Francis, Goh, Jeffrey, Baenziger, Olivia, Gibbs, Peter, Tran, Ben
Publicado 2021

A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Pat...

por Capdevila, Jaume, Klochikhin, Arkadiy, Leboulleux, Sophie, Isaev, Pavel, Badiu, Corin, Robinson, Bruce, Hughes, Brett G.M., Keam, Bhumsuk, Parnis, Francis, Elisei, Rossella, Gajate, Pablo, Gan, Hui K., Kapiteijn, Ellen, Locati, Laura, Mangeshkar, Milan, Faoro, Leonardo, Krajewska, Jolanta, Jarzab, Barbara
Publicado 2022

Health-Related Quality of Life Outcomes With Two Different Starting Doses of Lenvatinib in Combination With Everolimus for Previously Treated Renal Cell Carcinoma

por Bergerot, Cristiane, Young Rha, Sun, Pal, Sumanta, Koralewski, Piotr, Stroyakovskiy, Daniil, Alekseev, Boris, Parnis, Francis, Castellano, Daniel, Lyun Lee, Jae, Sunela, Kaisa, Ciuleanu, Tudor, Heng, Daniel, Glen, Hilary, Wang, Jinyi, Bennett, Lee, Pan, Janice, O’Hara, Karen, Puente, Javier
Publicado 2023

Modulation of Plasma Lipidomic Profiles in Metastatic Castration-Resistant Prostate Cancer by Simvastatin

por Mak, Blossom, Lin, Hui-Ming, Duong, Thy, Mahon, Kate L., Joshua, Anthony M., Stockler, Martin R., Gurney, Howard, Parnis, Francis, Zhang, Alison, Scheinberg, Tahlia, Wittert, Gary, Butler, Lisa M., Sullivan, David, Hoy, Andrew J., Meikle, Peter J., Horvath, Lisa G.
Publicado 2022

Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial

por Kelley, Robin Kate, Ryoo, Baek-Yeol, Merle, Philippe, Park, Joong-Won, Bolondi, Luigi, Chan, Stephen L, Lim, Ho Yeong, Baron, Ari D, Parnis, Francis, Knox, Jennifer, Cattan, Stéphane, Yau, Thomas, Lougheed, Julie C, Milwee, Steven, El-Khoueiry, Anthony B, Cheng, Ann-Lii, Meyer, Tim, Abou-Alfa, Ghassan K
Publicado 2020

Health-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUP

por Stockler, Martin R., Martin, Andrew J., Davis, Ian D., Dhillon, Haryana M., Begbie, Stephen D., Chi, Kim N., Chowdhury, Simon, Coskinas, Xanthi, Frydenberg, Mark, Hague, Wendy E., Horvath, Lisa G., Joshua, Anthony M., Lawrence, Nicola J., Marx, Gavin M., McCaffrey, John, McDermott, Ray, McJannett, Margaret, North, Scott A., Parnis, Francis, Parulekar, Wendy R., Pook, David W., Reaume, M. Neil, Sandhu, Shahneen, Tan, Alvin, Tan, Thean Hsiang, Thomson, Alastair, Vera-Badillo, Francisco, Williams, Scott G., Winter, Diana G., Yip, Sonia, Zhang, Alison Y., Zielinski, Robert R., Sweeney, Christopher J.
Publicado 2022